Literature DB >> 11422911

Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H.

N Amadei1, G V Baracho, V Nudelman, W Bastos, M P Florido, L Isaac.   

Abstract

Here we describe two new cases of complete deficiency of factor I (fI) in two sisters from a consanguineous Brazilian family. The eldest sibling (20-year-old) developed systemic lupus erythematosus (SLE) early during childhood while the youngest had been committed on several occasions owing to repeated infections although she was asymptomatic for auto-immune diseases. We also detected lower concentrations of C3 and factor B in both sisters. Biological functions dependent on complement activation such as the production of opsonins and killing of phagocytozed micro-organisms, chemotactic factors and haemolytic activity were all significantly reduced in both probands. Consistent with the absence of fI and low levels of fH, a deregulated production of C3b was observed by bidimensional electrophoresis in sera of both the probands.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422911     DOI: 10.1046/j.1365-3083.2001.00931.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  12 in total

1.  Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family.

Authors:  A S Grumach; M F Leitão; V G Arruk; M Kirschfink; A Condino-Neto
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Analysis of binding sites on complement factor I that are required for its activity.

Authors:  Sara C Nilsson; Izabela Nita; Lisa Månsson; Tom W L Groeneveld; Leendert A Trouw; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

3.  Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis.

Authors:  Fernando Louzada Strufaldi; Precil Diego Miranda de Menezes Menezes Neves; Cristiane Bitencourt Dias; Luis Yu; Viktoria Woronik; Livia Barreira Cavalcante; Denise Maria Avancini Costa Malheiros; Lectícia Barbosa Jorge
Journal:  J Nephrol       Date:  2021-02-11       Impact factor: 3.902

4.  Simple method to distinguish between primary and secondary C3 deficiencies.

Authors:  Marlene Pereira de Carvalho Florido; Patrícia Ferreira de Paula; Lourdes Isaac
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Atypical hemolytic uremic syndrome in the Tunisian population.

Authors:  Nadia Leban; Sabra Aloui; Dalel Touati; Ramzy Lakhdhar; Habib Skhiri; Gerard Lefranc; Abdellatif Achour; Mezri Elmay; Margarita Lopez-Trascasa; Pilar Sanchez-Corral; Jemni Chibani; Amel Haj Khelil
Journal:  Int Urol Nephrol       Date:  2010-05-25       Impact factor: 2.370

Review 6.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

7.  Molecular characterization of homozygous hereditary factor I deficiency.

Authors:  G V Baracho; V Nudelman; L Isaac
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 8.  SLE and infections.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

9.  Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Authors:  Kirsten L Rose; Danielle Paixao-Cavalcante; Jennifer Fish; Anthony P Manderson; Talat H Malik; Anne E Bygrave; Tao Lin; Steven H Sacks; Mark J Walport; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  The spectrum of renal thrombotic microangiopathy in lupus nephritis.

Authors:  Di Song; Li-hua Wu; Feng-mei Wang; Xiao-wei Yang; Di Zhu; Min Chen; Feng Yu; Gang Liu; Ming-hui Zhao
Journal:  Arthritis Res Ther       Date:  2013-01-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.